299 related articles for article (PubMed ID: 22357804)
1. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
Sun Z; Zhang J; Zhang X; Wang S; Zhang Y; Li C
Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
[TBL] [Abstract][Full Text] [Related]
3. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.
Evans J; Segal H
J Antimicrob Chemother; 2010 May; 65(5):897-900. PubMed ID: 20185419
[TBL] [Abstract][Full Text] [Related]
4. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
[TBL] [Abstract][Full Text] [Related]
5. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
Nosova EY; Bukatina AA; Isaeva YD; Makarova MV; Galkina KY; Moroz AM
J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
[TBL] [Abstract][Full Text] [Related]
8. Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis.
Fillion A; Aubry A; Brossier F; Chauffour A; Jarlier V; Veziris N
Antimicrob Agents Chemother; 2013 Sep; 57(9):4496-500. PubMed ID: 23836169
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
[TBL] [Abstract][Full Text] [Related]
10. Analysis of fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India.
Sulochana S; Narayanan S; Paramasivan CN; Suganthi C; Narayanan PR
J Chemother; 2007 Apr; 19(2):166-71. PubMed ID: 17434825
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.
Arjomandzadegan M; Titov L; Farnia P; Owlia P; Ranjbar R; Sheikholeslami F; Surkova L
Int J Mycobacteriol; 2016 Sep; 5(3):299-305. PubMed ID: 27847014
[TBL] [Abstract][Full Text] [Related]
12. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
[TBL] [Abstract][Full Text] [Related]
13. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.
Kam KM; Yip CW; Cheung TL; Tang HS; Leung OC; Chan MY
Microb Drug Resist; 2006; 12(1):7-11. PubMed ID: 16584301
[TBL] [Abstract][Full Text] [Related]
14. Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model.
Poissy J; Aubry A; Fernandez C; Lott MC; Chauffour A; Jarlier V; Farinotti R; Veziris N
Antimicrob Agents Chemother; 2010 Nov; 54(11):4765-71. PubMed ID: 20805388
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR;
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332
[TBL] [Abstract][Full Text] [Related]
16. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.
Niward K; Ängeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schön T
J Antimicrob Chemother; 2016 Feb; 71(2):333-8. PubMed ID: 26538509
[TBL] [Abstract][Full Text] [Related]
18. Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas.
El Sahly HM; Teeter LD; Jost KC; Dunbar D; Lew J; Graviss EA
J Clin Microbiol; 2011 Aug; 49(8):2942-5. PubMed ID: 21653760
[TBL] [Abstract][Full Text] [Related]
19. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A
Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
[TBL] [Abstract][Full Text] [Related]
20. Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
Chang KC; Yew WW; Chan RC
J Antimicrob Chemother; 2010 Aug; 65(8):1551-61. PubMed ID: 20542907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]